apixaban 2.5 MG Oral Tablet Eliquis
1 INDICATIONS AND USAGE ELIQUIS is a factor Xa inhibitor indicated: • to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. (1.1) • for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (1.2) • for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy. (1.3 , 1.4 , 1.5) 1.1 Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. 1.2 Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. 1.3 Treatment of Deep Vein Thrombosis ELIQUIS is indicated for the treatment of DVT. 1.4 Treatment of Pulmonary Embolism ELIQUIS is indicated for the treatment of PE. 1.5 Reduction in the Risk of Recurrence of DVT and PE ELIQUIS is indicated to reduce the risk of recurrent DVT and PE following initial therapy.
E.R. Squibb & Sons, L.L.C.
ROUND YELLOW 893 2 1 2
Related Pills
eliquis apixaban tablet film coated eliquis 30day starter pack apixaban kit
e.r. squibb & sons, l.l.c.
ELIQUIS apixaban 5 MG Oral Tablet Eliquis
E.R. Squibb & Sons, L.L.C.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied ELIQUIS (
APIXABAN) tablets are available as listed in the table below. Tablet Strength Tablet Color/Shape Tablet Markings Package Size NDC Code 2.5 mg yellow, round, debossed with “893” on Bottles of 60 0003-0893-21 biconvex one side and “2½” on the other side Hospital Unit-Dose Blister Package of 100 0003-0893-31 5 mg pink, oval, biconvex debossed with “894” on Bottles of 60 0003-0894-21 one side and “5” on the Bottles of 74 0003-0894-70 other side Hospital Unit-Dose Blister Package of 100 0003-0894-31 30-Day Starter Pack for Treatment of DVT and PE Containing 74 Tablets (1 blister pack of 42 tablets and 1 blister pack of 32 tablets) 0003-3764-74 Storage and Handling Store at 20°C to 25°C (68°F-77°F); excursions permitted between 15°C and 30°C (59°F-86°F) [see USP Controlled Room Temperature].
More pills like ROUND 893 2 1 2